The difference in prognostic value between high sensitive cardiac troponin T and I for long-term major adverse cardiovascular events in hemodialysis patients

Completed

• Conditions: Chronic hemodialysis patients; cardiac troponin; cardiovascular outcome; end-stage renal disease; hemodialysis; prognostic value

• Registration Number: TCTR20220322008
• Lead Sponsor: Faculty of medicine Chiang Mai University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-09-30
• Study Start: 2022-03-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 198

Inclusion Criteria

Age more than 18 years
ESRD patients with regular hemodialysis (two to three times a week) more than 90 days.

Exclusion Criteria

Recent diagnosis acute myocardial infarction, heart failure and pulmonary embolism within previous 6 months
Major surgery and trauma within previous 4 weeks
Pregnancy
Undergone coronary and/or valvular intervention within previous 6 months

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prognostic value of high sensitivity cardiac troponin T and I for all cause mortality 1 year Mortality rate

Secondary Outcome Measures

Name	Time	Method
Prognostic value of high sensitivity cardiac troponin T and I for major adverse cardiovascular events 1 year Number of event